Osaic Holdings
LYEL icon

Osaic Holdings’s Lyell Immunopharma LYEL Stock Holding History

Osaic Holdings’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-124
Closed -$2.49K – 8106
2026
Q1 		$2.49K Hold
124
– – ﹤0.01% 6970
2025
Q4 		$3.82K Buy
+124
New +$2.77K ﹤0.01% 6841
2023
Q3 		– Sell
-385
Closed -$24.2K – 7473
2023
Q2 		$24.2K Hold
385
– – ﹤0.01% 5438
2023
Q1 		$20.6K Sell
385
-10
-3% -$535 ﹤0.01% 5557
2022
Q4 		$27K Buy
395
+383
+3,192% +$38K ﹤0.01% 5364
2022
Q3 		$2K Buy
+12
New +$1.63K ﹤0.01% 6791

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Osaic Holdings's LYEL Position: Q2 2026 in Review

Osaic Holdings sold out of Lyell Immunopharma (LYEL) in Q2 2026, closing a stake of 124 shares — an estimated $2.49K sold.

Osaic Holdings first reported a position in LYEL in Q3 2022 and held it in 6 quarters. The position peaked at $27K in Q4 2022. 87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Osaic Holdings reported no remaining Lyell Immunopharma position as of Q2 2026 after selling out during the quarter.
  • Osaic Holdings sold 124 Lyell Immunopharma shares in Q2 2026, an estimated $2.49K.
  • Osaic Holdings first reported a position in Lyell Immunopharma in Q3 2022 and held it in 6 quarters.
  • Osaic Holdings's Lyell Immunopharma position peaked at $27K in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.